U.S. Luxury Stock News

NYSE:VIK
NYSE:VIKHospitality

Is It Too Late To Consider Viking Holdings (VIK) After A 109% One Year Rally?

If you are wondering whether Viking Holdings stock still offers value after a strong run, or if you might be late to the story, this article breaks down what the current price could be indicating. The stock last closed at US$92.55, with returns of 11.3% over 7 days, 14.5% over 30 days, 28.1% year to date, and 108.8% over the past year. This performance may have reshaped how many investors think about its risk and reward profile. Recent coverage has focused on Viking Holdings as a major...
NasdaqGS:CEVA
NasdaqGS:CEVASemiconductor

A Look At CEVA (CEVA) Valuation After Analyst Upgrades And Earnings Outlook Shift

Recent interest in CEVA (CEVA) has picked up after analyst upgrades and improved full year earnings estimates, with investors also watching the stock ahead of its presentations at two major technology conferences. See our latest analysis for CEVA. The recent analyst upgrades and conference appearances come against a backdrop of strong momentum, with CEVA’s share price delivering a 49.41% 1 month return and an 80.87% year to date return, while the 1 year total shareholder return sits at...
NYSE:A
NYSE:ALife Sciences

Agilent Product Suite Refresh Raises Questions On Adoption And Valuation Potential

Agilent Technologies (NYSE:A) has introduced a suite of new laboratory instruments, including the 8890B and 8860B GC with GC Assist, a MAM workflow for biopharma QC labs, the 9500 Triple Quadrupole ICP-MS, and the 1290 Infinity III Fluorescence Detector. The launches target chromatography, mass spectrometry, and quality control workflows, with a focus on automation, remote monitoring, and regulatory support across pharma, food, environmental, and materials labs. These products represent a...
NYSE:DOW
NYSE:DOWChemicals

Is It Too Late To Consider Dow (DOW) After A 42% Year To Date Surge

If you are wondering whether Dow at US$34.49 is still offering value after a strong run, this breakdown will help you frame that question with numbers, not guesswork. The stock is up 42.1% year to date and 29.9% over the past year, even though it has fallen 4.9% over the last week and 9.5% over the last month, which can change how the market is viewing both opportunity and risk. Recent coverage has focused on Dow as a key player in the US materials sector, with attention on how its share...
NasdaqGS:HURN
NasdaqGS:HURNProfessional Services

Huron Consulting Group’s Revenue Growth Vs Share Price Pullback Attracts Scrutiny

Huron Consulting Group reported an 11.8% year-on-year revenue increase in its latest first quarter. The company exceeded earnings expectations, reflecting continued operational improvement. These results extend a multi year pattern of growth and capital returns, including share repurchases. The update arrives as NasdaqGS:HURN trades at $104.74 after a recent pullback in the share price. For investors tracking NasdaqGS:HURN, the picture is mixed at first glance. The stock is down 17.6% over...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Assessing Verra Mobility (VRRM) Valuation After Recent Share Price Weakness

Stock performance snapshot Verra Mobility (VRRM) has been under pressure, with the stock down about 0.7% over the past day and roughly 0.8% year to date, while the past year and past 3 months also reflect sizeable declines. At a recent close of US$3.85 and a market cap of about US$2.0b, the company sits against a backdrop of reported annual revenue of US$979.39m and net income of US$131.04m across its three core segments. See our latest analysis for Verra Mobility. The recent share price...
NYSE:ABBV
NYSE:ABBVBiotechs

Is AbbVie (ABBV) Still Attractive After A 21.5% One Year Share Price Gain?

If you are wondering whether AbbVie stock still offers value after a strong run, it is important to see how different valuation methods line up against the current share price. The stock recently closed at US$215.40, with returns of 1.5% over the past week, 9.1% over the past month, and 21.5% over the past year, while year to date it is down 6.1%. Recent coverage has focused on AbbVie's position in the large cap pharmaceuticals and biotech space and how investors weigh long term drug...
NYSE:CARR
NYSE:CARRBuilding

Diamond Hill Capital Backs Carrier Global Story On Margins And Growth

Diamond Hill Capital has initiated a new position in Carrier Global (NYSE:CARR), focusing on the company's resilience and operational strengths. The investment highlights expectations for market share gains and margin improvement opportunities, despite current pressure in residential markets. The move adds another institutional holder to Carrier Global's shareholder base at a share price of $64.51. For you as an investor, this fresh interest in NYSE:CARR comes as the stock trades around...
NasdaqCM:BLTE
NasdaqCM:BLTEPharmaceuticals

Will Widening Losses and Renewed Buy Ratings Change Belite Bio's (BLTE) Narrative?

Belite Bio, Inc recently reported a first-quarter 2026 net loss of US$26.94 million, widening from US$14.28 million a year earlier, and participated in the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026), where Ruifang Sui presented on the company’s retinal disease work. Even as losses increased and the company remains pre-revenue, renewed Buy ratings from major brokers and scientific visibility at Retina China 2026 have kept attention on Belite Bio’s...
NasdaqCM:DUOT
NasdaqCM:DUOTSoftware

Does Duos Technologies Group (DUOT) Reaffirmed 2026 Revenue Outlook Test Management’s Credibility Or Highlight Strategic Conviction?

Earlier in May 2026, Duos Technologies Group, Inc. reported first-quarter 2026 results showing revenue of US$2.72 million, a widening net loss of US$3.49 million, and then reaffirmed its expectation for full-year 2026 revenue to exceed US$50 million while also planning a presentation at the Craig-Hallum 23rd Annual Institutional Investor Conference in Minneapolis on May 28, 2026. This combination of weaker quarterly performance, reiterated full-year revenue ambitions, and outreach to...
NasdaqGS:CAR
NasdaqGS:CARTransportation

Is It Too Late To Consider Avis Budget Group (CAR) After Strong 1 Year Share Gains?

If you are wondering whether Avis Budget Group's share price still offers value after past gains or if most of the upside is already reflected, this article walks through what the current valuation might be telling you. The stock last closed at US$165.10, with returns of 8.0% over the past week, down 11.7% over the past month, up 28.8% year to date, and up 37.0% over the last year. Recent share price moves have kept investor attention on how the market is pricing in Avis Budget Group's...
NYSE:INGM
NYSE:INGMElectronic

Ingram Micro Holding (INGM) Deepens HPE Ties With Global Distribution Deal Is The Moat Widening?

In May 2026, Ingram Micro Holding Corporation announced it had been selected as a Global Distributor for HPE, gaining access to HPE’s entire networking, cloud, and AI portfolio and extending its HPE Partner Growth Accelerator Program worldwide. This expanded relationship deepens Ingram Micro’s role in enterprise infrastructure by pairing full HPE portfolio access with its Xvantage digital platform and global HPE‑focused teams. Next, we’ll examine how becoming one of only two global HPE...